This article is more than 5 years old. Information may no longer be current.

Iridex broadens availability of noninvasive glaucoma therapy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MOUNTAIN VIEW, Calif. — An in-office, tissue-sparing, noninvasive trabeculoplasty procedure based on MicroPulse technology has been launched by Iridex with its green laser system, according to a press release.

The availability of MicroPulse Laser Trabeculoplasty was announced at the American Society of Cataract and Refractive Surgery meeting in Chicago.

The IQ 532 green laser system is a versatile platform used by a broad group of ophthalmologists, the release said.

The MicroPulse procedure works by dividing laser emissions into trains of microsecond pulses, according to the release. This allows the physician to better control the impact on target tissues, resulting in less collateral damage.

The IQ 532 system also can be used to treat diabetic macular edema, proliferative diabetic retinopathy and retinal tears, the release aid. The MicroPulse Laser Trabeculoplasty procedure offers the potential to lower IOP in glaucoma patients without additional thermal damage from the laser.